All Insights
Exploring the science, practice, and business of medicine.
Exploring the science, practice, and business of medicine.
Showing 10 out of 68 Insights
Discover key strategies for physicians to stay ahead in the evolving landscape of health care, from embracing technology to fostering leadership skills.
John Torous, MD, MBI, director of digital psychiatry at Beth Israel Deaconess Medical Center and an advisor for the NIH All of Us Research Program, discusses driving toward the next level in digital health with patient-generated data.
Explore how thoughtful design, collaboration, and user-centered strategies are shaping the future of health care innovation.
Discover how innovative strategies and global collaboration are tackling health disparities exposed by COVID-19 and shaping the future of equitable health care.
Megan Jones Bell, PsyD, chief strategy and science officer at Headspace, discusses evolving business models and creating paths to reimbursement for digital health apps.
Anupam B. Jena, MD, PhD, the Ruth L. Newhouse Associate Professor of Health Care Policy at Harvard Medical School and a faculty research fellow at the National Bureau of Economic Research, discusses using creative thinking to devise natural experiments that can help guide health care and spending.
Rebecca Miksad, MD, MPH, a senior medical director of Flatiron Health, medical oncologist and health outcomes researcher, discusses how real-world data address regulatory and drug development challenges.
Jagpreet Chhatwal, PhD, an assistant professor at Harvard Medical School and decision scientist at MGH Institute for Technology Assessment, discusses the challenges of building an interactive COVID-19 modeling tool and its real-world impact.
Robert M. Plenge, MD, PhD, senior vice president in research and early development and head of the immunology, cardiovascular, fibrosis, and global health research team at Bristol Myers Squibb, discusses leveraging genetic insights in drug discovery.
Lauren Orefice, PhD, assistant professor in the Department of Genetics at the Blavatnik Institute at Harvard Medical School and the Department of Molecular Biology at Massachusetts General Hospital, discusses steps toward translating promising science into novel treatments for autism.